Inhibition of inflammatory cytokines - potential new treatment for diabetic nephropathy
Type II diabetes mellitus is currently on the rise and reaching epidemic proportions in the United States. In addition to this increase, the number of cases of diabetic complication such as kidney disease has increased. Currently diabetic kidney disease is the leading cause for end stage renal disea...
Main Author: | Correia, Amanda |
---|---|
Language: | en_US |
Published: |
2016
|
Subjects: | |
Online Access: | https://hdl.handle.net/2144/16106 |
Similar Items
-
Increased serum concentrations of inflammatory cytokines in type 2 diabetic patients with chronic kidney disease
by: V I Konenkov, et al.
Published: (2015-06-01) -
Patterns of Toll-Like Receptor Expressions and Inflammatory Cytokine Levels and Their Implications in the Progress of Insulin Resistance and Diabetic Nephropathy in Type 2 Diabetic Patients
by: Rofyda H. Aly, et al.
Published: (2020-12-01) -
Inflammatory Cytokines in Diabetic Kidney Disease: Pathophysiologic and Therapeutic Implications
by: Javier Donate-Correa, et al.
Published: (2021-01-01) -
Renal expression of cytokines and chemokines in diabetic nephropathy
by: Liliane Silvano Araújo, et al.
Published: (2020-07-01) -
Evaluation of cytokines in type 1 diabetes patients with and without retinopathy
by: Jéssica F. Cardoso, et al.